REFERENCES
- Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1988;6(12):1838— 1844.
- Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG. Treatment of elderly patients with intermediate-and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Ann Hematol 2001;80(3):155— 159.
- Havlik RJ, Yancik R, Long S, Ries L, Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994;74(7 Suppl):2101–2106.
- Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP. Cyclophosphamide, pegylated liposomal doxor-ubicin (Caelyx), vincristine and prednisone (C COP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. Haematologica 2002;87(8):822–827.
- Tsavaris N, Kosmas C, Vadiaka M, Giannouli S, Siakantaris MP, Vassilakopoulos T. Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma. Anticancer Res 2002;22(3): 1845 — 1848.
- Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R. CHOP chemotherapy plus rituximab com-pared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346(4):235–242.
- Mounier N, Briere J, Gisselbrecht C, Emile JF, Lederlin P, Sebban C. Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood 2003;101(11):4279–4284.
- Pfreundschuh M, Truemper L, Kloess M, Schmits R, Feller AC, Ruebe C, Rudolph C, Reiser M, Hossfeld DK, Eimermacher H, Hasenclever D, Schmitz N, Loeffler M. 2-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004;104: 636— 661.